InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Sherman Matthew L, EVP et Directeur Médical. Insider active across 1 company, notably Deciphera Pharmaceuticals, Inc.. In total, 15 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €288k. History available since 4 October 2021. The latest transaction was disclosed on 15 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations15 total
34,157 sharesCommon StockSEC:0000950170-24-072223:0
17,275 shares0Common StockSEC:0000950170-24-017085:0
▼
2,435 shares@ US$14.46978.7% of flowCommon StockSEC:0000950170-24-005393:0
8,244 sharesCommon StockSEC:0000950170-23-070382:0
8,244 sharesCommon StockSEC:0001209191-23-053939:0
▼
2,942 shares@ US$12.689.6% of flowCommon StockSEC:0001209191-23-051886:0
▼
1,655 shares@ US$14.40185.9% of flowCommon StockSEC:0001209191-23-038756:0
16,488 shares0Common StockSEC:0001209191-23-010506:0
▼
2,403 shares@ US$21.241312.7% of flowCommon StockSEC:0001209191-23-003998:0
▼
2,587 shares@ US$18.7313.3% of flowCommon StockSEC:0001209191-22-052717:0
▼
1,768 shares@ US$10.759.7% of flowCommon StockSEC:0001209191-22-038432:0
984 shares@ US$9.054.2% of flowCommon StockSEC:0001209191-22-011361:0
20,500 shares0Common StockSEC:0001209191-22-004076:0
11,100 shares0Common StockSEC:0001209191-21-070232:0
▼
2,659 shares@ US$33.1740.9% of flowCommon StockSEC:0001209191-21-059804:0
15 of 15 declarations
About Sherman Matthew L
Matthew L. Sherman serves as EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. He is responsible for leading the company's medical and research initiatives. Matthew plays a key role in developing innovative treatments and improving patient outcomes. His medical expertise is essential for Deciphera's mission.
